ADORA2A and neoplasm: It has been demonstrated that A2AR is broadly expressed on several immune cells, including tumor-associated macrophages (TAMs), CD4+ regulatory T cells (Tregs), effector CD4+ T cells, and cytotoxic T lymphocytes at distant levels, in the TME of major solid cancers [8,31].